NRx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TRUIST FINANCIAL CORP | 01/31/2025 | 38,965 | $4,988 | 0.00% | 0.36% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 25,516 | $4,000 | -26.44% | 0.23% |
| WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 5,190 | $664 | -66.28% | 0.05% |
| UBS GROUP AG | 02/14/2025 | 3,911 | $501 | -74.36% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 15 | $2 | 0.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JOHNSON FINANCIAL GROUP, INC. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NRx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of NRx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
TRUIST FINANCIAL CORP: 38,965
Virtu Financial LLC: 25,516
WOLVERINE ASSET MANAGEMENT LLC: 5,190
UBS Group AG: 3,911
Tower Research Capital LLC (TRC): 15
Johnson Financial Group, Inc.: 0
0.67% of NRx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73,692 shares in the last 24 months. This purchase volume represents approximately $29,477 in transactions.